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Abstract
The mammalian homotypic fusion and vacuole protein sorting (HOPS)
complex is comprised of six subunits: VPS11, VPS16, VPS18, VPS39,
VPS41 and the Sec1/Munc18 (SM) family member VPS33A. Human
HOPS has been predicted to be a tethering complex required for fusion
of intracellular compartments with lysosomes, but it remains unclear
whether all HOPS subunits are required. We showed that the whole
HOPS complex is required for fusion of endosomes with lysosomes
by monitoring the delivery of endocytosed ﬂuorescent dextran to lyso-
somes in cells depleted of individual HOPS proteins. We used the crystal
structure of the VPS16/VPS33A complex to design VPS16 and VPS33A
mutants that no longer bind each other and showed that, unlike the
wild-type proteins, these mutants no longer rescue lysosome fusion with
endosomes or autophagosomes in cells depleted of the endogenous pro-
teins. There was no effect of depleting either VIPAR or VPS33B, paralogs
of VPS16 and VPS33A, on fusion of lysosomes with either endosomes
or autophagosomes and immunoprecipitation showed that they form
a complex distinct from HOPS. Our data demonstrate the necessity of
recruiting the SM protein VPS33A to HOPS via its interaction with VPS16
and that HOPS proteins, but not VIPAR or VPS33B, are essential for
fusion of endosomes or autophagosomes with lysosomes.
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In mammalian cells, the transport of macromolecules
to the lysosome depends on tightly regulated multi-step
processes involving bi-directional vesicular transport and
membrane fusion between distinct organelles. During
endocytosis, mammalian cells take up cell-surface mem-
brane proteins, bound ligands, lipids and extracellular
fluid into vesicles that subsequently fuse with early endo-
somes. These mature into late endosomes (also known as
multivesicular bodies) that fuse with lysosomes to form
endolysosomes (1,2). Similarly,macroautophagy (hereafter
referred to as autophagy) delivers intracellular macro-
molecules and organelles for degradation by lysosomal
hydrolases via fusion of autophagosomes with lysosomes
to form autolysosomes (3,4). Much of the protein machin-
ery required for traffic through the mammalian endocytic
and autophagic pathways comprises homologs of proteins
first identified in yeast on pathways to the vacuole, which
is the yeast counterpart of the mammalian lysosome. In
yeast, the heterohexameric homotypic fusion and vacuole
protein sorting (HOPS) complex, comprising the vacuolar
protein sorting (Vps) proteins Vps11p, Vps16p, Vps18p,
Vps33p, Vps39p and Vps41p, has been shown to be a Rab
GTPase-dependent tethering complex required for fusion
of vacuoles with transport vesicles or other vacuoles (5–9).
Yeast HOPS aids in trans-SNARE complex assembly, pro-
tects SNARE complexes from disassembly and promotes
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membrane fusion (10–12). In addition, yeast Vps39p has
been reported to act independently of the remainder of the
HOPS complex in creating contact sites between vacuoles
and mitochondria (13,14) and it is also proposed to play
a role in controlling the activity of target of rapamycin
complex 1 (TORC1) (15). Very little is known about how
the metazoan HOPS complex functions at the mechanistic
level, although functionally some or all HOPS proteins
have been shown to be required for the maturation of
endosomes (16), homotypic fusion of late endosomes
(17), the delivery of endocytosed cargo to lysosomes
(17–19), the biogenesis of lysosome related organelles
[LROs; (18–21)], Ebola virus entry into cultured cells
(22), the resistance of melanoma cells to cytotoxic agents
(23), the fusion of phagosomes with lysosomes (24–26)
and fusion of autophagosomes with lysosomes (27–29).
There is also evidence that the mammalian HOPS protein
VPS41 has additional functions that are independent of the
complex in the fusion of lysosome-associated membrane
protein (LAMP) carriers with late endosomes (30), and
the biogenesis of regulated secretory granules (31). In
addition, it has been proposed that mammalian VPS18
may be involved in controlling the levels and localization
of the serine/threonine-specific protein kinase AKT2 on
endosomes, thus potentially playing a role in the regulation
of signalling pathways (32).
It is now known that a related complex, the class C
core vacuole/endosome tethering (CORVET) com-
plex, which is involved in tethering and fusion of early
endosomes (33–38), is present in Saccharomyces cere-
visiae, Caenorhabditis elegans and mammals. HOPS and
CORVET share four core subunits (Vps11p, Vps16p,
Vps18p and Vps33p in yeast), with mammalian CORVET
having the two accessory subunits VPS8 and TGF-
BRAP1/TRAP1 (homolog of yeast Vps3p) instead of
VPS39 and VPS41 in HOPS (33,37,39). It is also appar-
ent that metazoans have two paralogs of both yeast
Vps33p and Vps16p, but there is currently a lack of clarity
about whether both paralogs of VPS16 (VPS16/VPS16A
and VIPAR/VIPAS39/SPE-39/VPS16B) and VPS33
(A and B) can be part of HOPS and/or CORVET
(33,38,40,41).
VPS33A and VPS33B are members of the Sec1/Munc18
(SM) family of proteins that, together with SNAREs,
comprise the core membrane fusion machinery in eukary-
otes and interact with tethering complexes [reviewed in
(42,43)]. Recently, we solved the crystal structure of the
human SM protein VPS33A in complex with a fragment of
VPS16 (44), and a similar structure was solved by others
with proteins from the thermophilic fungus Chaetomium
thermophilum (45). We proposed that the structure of
VPS33A in complex with VPS16 represents the archetypal
interaction between SM proteins and tethering complexes
(44). These studies have given us a structural framework
to study the functional importance of the association
between an SM protein and a tethering complex. We have
therefore established cell-based assays for both endosome-
and autophagosome–lysosome fusion events to test the
importance of the VPS33A/VPS16 interface, and thus
recruitment of SM protein activity to the HOPS complex,
for HOPS-dependent membrane fusion. We have also
addressed the question of whether VPS33B and VIPAR
can functionally substitute for VPS33A and VPS16. Our
results show that the association of human VPS33A with
HOPS via its interaction with VPS16 is required for
both endosome- and autophagosome–lysosome fusion.
Further, we found that neither VPS33B nor VIPAR are
required for these fusion events and are physically neither
part of the human HOPS complex nor of the human
CORVET complex.
Results
All components of the human HOPS complex are
essential for fusion of endosomes and lysosomes but
VIPAR and VPS33B are not required
In order to study the function of human HOPS proteins
in the regulation of membrane fusion in the late endo-
cytic pathway of cultured cells we employed a modified
version of a previously published protocol (17) to visualize
the delivery of endocytosed fluorescent-labelled dextran
to enzymatically active endolysosomal/lysosomal com-
partments. In this assay, we depleted individual HOPS
proteins in cultured HeLaM cells with small interfering
RNA (siRNA) and quantified the mixing of endocy-
tosed green fluorescent dextran Alexa Flour® 488, which
had been chased into the endocytic pathway, with the
red fluorescent cresyl violet product of hydrolysis of
Magic Red®, a substrate for the lysosomal acid hydrolase
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Cathepsin B. Depletion of any of the components of
human HOPS complex, VPS11, VPS16, VPS18, VPS33A,
VPS39 or VPS41 (Figure 1A), inhibited fusion of dex-
tran Alexa Flour 488-positive endosomes with Magic
Red®-positive lysosomes (Figure 1B,C and Figure S1).
In contrast, knock-down of VIPAR or VPS33B, which
previously were suggested to be alternative subunits for
VPS16 and VPS33A in HOPS (40,41), had no effect on
the delivery of dextran Alexa Flour 488 from endosomes
to lysosomes (Figure 1B,C). We determined by fluores-
cent activated cell sorting (FACS) analysis that the total
fluorescence of both fluorescent markers was the same
for all genotypes analysed (Figure 1D,E). These data are
consistent with a previous study showing that depletion
of VPS39 or VPS41 had no effect on fluorescent dextran
uptake or the number of Magic Red®-positive lysosomes
despite impairing delivery of the dextran to lysosomes
(17). The difference between the results that we obtained
after depleting the HOPS proteins or VIPAR and VPS33B
can neither be explained by different amounts of dextran
Alexa Flour 488 uptake nor by differences in the over-
all Magic Red® signal from lysosomes. Analysis of the
knock-down efficiencies by quantitative real-time PCR
or immunoblotting indicated similar levels of depletion
(∼80%) between all genotypes analysed (Figure 1F,G).
Taken together, these data show that all human HOPS
components, but not VIPAR or VPS33B, are required for
the fusion of endosomes with lysosomes in HeLaM cells.
Recruitment of VPS33A to the HOPS complex via
interaction with VPS16 is required
for endosome–lysosome fusion
To test whether the interaction of VPS33A and the rest
of HOPS is required for endosome–lysosome fusion,
we mutated in VPS16 the critical residues alanine 669
(A669D) and/or arginine 725 (R725E), which we have
previously shown to be required for binding of VPS16 to
VPS33A without substantially altering folding or stability
[(44), Figure 2A]. siRNA-resistant HA-tagged wild-type
HA-VPS16(WT) or mutant HA-VPS16(A669D), HA-
VPS16(R725E), or HA-VPS16(A669D/R725E) were stably
expressed in HeLaM cells. Expression of HA-VPS16(WT)
rescued the block in endosome–lysosome fusion observed
upon depletion of endogenous VPS16 after transfection
with a single siRNA oligonucleotide (oligo3; Figure 2B,C).
Expression of VPS16 containing single mutations of
either of the amino acids A669 or R725, present at
the binding interface with VPS33A, also rescued the
block in endosome–lysosome fusion, although the
rescue was only partial when expressing the single
mutant HA-VPS16(A669D) (Figure 2B,C). This result
may arise from residual binding of these VPS16 point
mutants to VPS33A: we previously observed that puri-
fied VPS33A-GST can pull-down myc-VPS16(A669D)
and myc-VPS16(R725E) produced by in vitro tran-
scription/translation, although both are pulled down
much less efficiently than is myc-VPS16(WT) [see
Fig. 5A in (44)]. We conclude that our immunopre-
cipitation experiments (Figure 2D) are less sensitive
than the previous pull-down experiments in detecting
the interaction of VPS16 with VPS33A, and that the
presence of minute amounts of HOPS complex con-
taining VPS33A, undetectable by immunoprecipitation,
is sufficient to support delivery of the endocytosed
dextran from endosomes to lysosomes. Expression of
the double mutant HA-VPS16(A669D/R725E), which
also cannot immunoprecipitate endogenous VPS33A
(Figure 2D), failed to rescue the block in endosome–
lysosome fusion in two independent clonal HeLaM cell
lines (Figure 2B,C). It should be noted that both of the
single mutants of HA-VPS16 and the double mutant
were able to co-immunoprecipitate VPS18 to a similar
extent, consistent with them all being correctly folded
and incorporated into the HOPS complex (Figure 2D).
The block in endosome–lysosome fusion upon expression
of the double mutant HA-VPS16(A669D/R725E) in the
cells depleted of endogenous VPS16 clearly shows that the
association between VPS33A and VPS16 is required for
endosome–lysosome fusion. This was confirmed when
we mutated residues in VPS33A, lysine 429 (K429D),
tyrosine 438 (Y438D) and isoleucine 441 (I441K), which
we had previously shown to be required for the binding
to VPS16 [(44), Figure 3A]. siRNA-resistant haemagglu-
tinin (HA)-tagged wild-type VPS33A(WT)-HA or three
different double mutants, VPS33A(K429D/I441K)-HA,
VPS33A(Y438D/I441K)-HA or VPS33A(K429D/ Y438D)
-HA, were stably expressed inHeLaM cells and their ability
to support fusion of endosomes with lysosomes was anal-
ysed after depletion of endogenousVPS33Aby transfection
with a single oligonucleotide (oligo2; Figure 3B–C). As
observed for VPS16, expression of VPS33A(WT)-HA
rescued the block in endosome–lysosome fusion detected
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upon depletion of endogenous VPS33A, whilst all three
double mutants failed to rescue. Immunoblot analysis
after immunoprecipitation with an anti-VPS18 antibody
and detection of the HA-tagged proteins confirmed that
the inability of VPS33A(K429D/I441K)-HA, VPS33A
(Y438D/I441K)-HA and VPS33A(K429D/Y438D)-HA
to rescue the block in endosome–lysosome fusion was
due to their loss of interaction with the remainder of the
HOPS complex (Figure 3D). The inability of the double
mutants to rescue when compared to VPS33A(WT)-HA
was not due to different levels of expression (Figure 3E).
Taken together, our data demonstrate that the recruit-
ment of VPS33A to the HOPS complex via its interaction
with VPS16 is crucial for endosome–lysosome fusion in
mammalian cells.
VPS16 and VPS33A, but not VIPAR or VPS33B, are
required for fusion of autophagosomes with lysosomes
All components of mammalian HOPS complex have
previously been shown to be required in the final step
of macroautophagy, the fusion of autophagosomes
with lysosomes, although conflicting data has been
reported for VPS16 (28,29,46). Our depletion experi-
ments described above led us to conclude that VIPAR
and VPS33B do not play a role in endosome–lysosome
fusion (Figure 1), but we also investigated whether they
function in autophagosome–lysosome fusion (Figure 4).
To this end, VPS16, VPS33A, VIPAR or VPS33B were
depleted in HeLaM cells stably expressing the pH sensitive
autophagy marker mRFP-GFP-LC3 (47,48). In these cells,
because of the coincident fluorescent signal from both
mRFP and GFP, autophagosomes appear yellow in merged
confocal images. After the fusion of autophagosomes with
lysosomes, the GFP fluorescence is quenched by acidic pH
and autolysosomes show only a mRFP signal. The fusion
of autophagosomes with lysosomes can be inhibited by a
6-h incubation with 400 nM bafilomycinA1 (49), which
leads to the accumulation of yellow autophagosomes in
contrast to control cells that show many red autolyso-
somes and only a small number of yellow autophagosomes
(Figure 4A). Depletion of either VPS16 or VPS33A caused
a significant accumulation of yellow autophagosomes in
the HeLaM cells expressing mRFP-GFP-LC3 that was
comparable to control cells transfected with non-targeting
siRNAand then treatedwith bafilomycinA1 (Figure 4A). In
cells depleted of either VPS16 or VPS33A, treatment with
bafilomycinA1 had no additional effect on the inhibition of
autophagosome–lysosome fusion (Figure 4A). In contrast
to depletion of VPS16 or VPS33A, knock-down of VIPAR
or VPS33B had no effect on autophagosome–lysosome
fusion. These cells contained mainly red autolysosomes
and only a few yellow autophagosomes, similar to
non-targeting siRNA treated cells (Figure 4A). Treat-
ment of VIPAR or VPS33B knock-down cells with
bafilomycinA1 inhibited autophagosome–lysosome
fusion, consistent with there being no disruption of
the autophagy pathway upon depletion of VIPAR and
VPS33B.
Figure 1: siRNA depletion of HOPS components but not VIPAR or VPS33B inhibits the fusion of endosomes with
lysosomes. HeLaM cells were transfected twice with a single siRNA oligonucleotide or a pool of four siRNA oligonucleotides at 100 nM.
A) Schematic model of the human HOPS complex (44). B) Colocalisation of dextran Alexa Fluor® 488 with Magic Red® using images
captured by live-cell confocal microscopy after knock-down of HOPS proteins with siRNA oligonucleotide pools (NT: non-targeting
siRNA). Mean± SEM of three independent experiments with ﬁve ﬁelds each, ≥30 cells total per condition. *p< 0.01, **p< 0.003,
***p< 0.0004, NS, not signiﬁcant, using two-tailed unpaired t-test. C) Representative live-cell confocal microscopy images of cells
quantiﬁed in (B) that had been loaded with dextran Alexa Fluor 488 10,000MW (green) for 2 h, chased for 1 h and then stained with
Magic Red® (red) for lysosomes. Scale bar 5 μm. D) FACS analysis of dextran Alexa Fluor 488 ﬂuorescence after uptake as in (B) and
(C). E) FACS analysis of Magic Red® ﬂuorescence of cells treated as in (B) and (C). For both (D) and (E), 30,000 cells were measured per
condition, with representative traces shown for each condition from one of three independent experiments. Data were analysed using
FLOWJO software and histogram overlays are displayed as %Max, scaling each curve to mode= 100%. F) RNA was puriﬁed from cells
and transcribed into cDNA. The knock-down efﬁciency was evaluated by quantitative real-time PCR with gene-speciﬁc primers (Table
S1). Detection of Actin transcripts served as a reference.ΔΔCt values were calculated and relative transcript levels of three independent
experiments are shown as mean± SD. G) Protein lysates were analysed by immunoblotting with speciﬁc VPS18 or VPS33A antibodies
to conﬁrm knock-down efﬁciencies. Actin served as loading control.
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To characterize the autophagy phenotype further, we
immunostained endogenous LC3 in HeLaM cells
transfected with a non-targeting siRNA or siRNA to
deplete VPS16, VPS33A, VIPAR or VPS33B (Figure 4B,C).
Quantification of the fluorescence signal confirmed a
significant accumulation of LC3-positive autophago-
somes after depletion of VPS16 or VPS33A when
compared to control cells treated with non-targeting
siRNA. No autophagosome accumulation was observed
after depletion of VIPAR or VPS33B (Figure 4B,C). In
these experiments we observed a greater accumulation of
LC3-positive structures following depletion of VPS16 than
after depletion of VPS33A (Figure 4B,C). The results show
that VPS33A and VPS16, but not VIPAR and VPS33B, are
required for the fusion of autophagosomes with lysosomes.
Recruitment of VPS33A to the HOPS complex via
interaction with VPS16 is required
for autophagosome–lysosome fusion
To test whether the interaction of VPS33A with the rest of
HOPS via binding toVPS16 is required for autophagosome
–lysosome fusion we immunostained endogenous LC3
in HeLaM cells depleted of endogenous VPS16 but
stably expressing siRNA-resistant HA-VPS16(WT),
HA-VPS16(A669D), HA-VPS16(R725E) or HA-VPS16
(A669D/R725E). Images obtained by confocal microscopy
and quantification of LC3 fluorescence on images cap-
tured by automated microscopy showed that expression of
HA-VPS16(WT) rescued the block in autophagosome–
lysosome fusion observed upon VPS16 knock-down in
HeLaM cells (Figure 5A–C). Expression of both single
mutants, VPS16(A669D) and HA-VPS16(R725E), showed
a tendency towards the cells having more autophagosomes
in images taken by confocal microscopy (Figure 5A).
However, when we quantified LC3 staining by auto-
mated microscopy there were no significant differences
in the ability of VPS16(A669D) or HA-VPS16(R725E)
to rescue the block in autophagosome–lysosome fusion
when compared with HA-VPS16(WT) (Figure 5B,C). As
discussed above, this is probably due to some residual
binding activity of the single mutants to VPS33A that
was below the sensitivity of detection by immunopre-
cipitation. Stable expression of the double mutant HA-
VPS16(A669D/R725E) failed to rescue the block in
autophagosome–lysosome fusion observed upon VPS16
knock-down. Thus, the recruitment of VPS33A to
the HOPS complex via its interaction with VPS16
is required for autophagosome–lysosome fusion in
HeLaM cells.
VIPAR and VPS33B are not part of the HOPS complex
Our experiments showed that all HOPS proteins, but
not VIPAR or VPS33B, are required for the delivery of
endocytic cargo to lysosomes and for autophagosome–
lysosome fusion (Figure 1). To test whether VIPAR or
VPS33B is physically present in the HOPS complex, lysates
from HeLaM cells stably expressing C-terminally GFP-
tagged VPS16, VPS33A, VIPAR, or VPS33B, or tran-
siently expressing GFP alone, were incubated with
an antibody against endogenous VPS18 (Figure 6A).
Co-immunoprecipitation of VPS18 was observed with
VPS16-GFP and VPS33A-GFP, but not with VIPAR-GFP,
VPS33B-GFP or GFP. The reciprocal experiment, in
which the GFP-tagged proteins were captured on a GFP
Figure 2: The association of VPS33A with HOPS via VPS16 is essential for endosome–lysosome fusion. Analysis of
HeLaM cells or HeLaM cells stably expressing N-terminally haemagglutinin (HA)-tagged siRNA oligonucleotide 3 (oligo3)-resistant
VPS16 wild type (WT), single mutant (A669D, A725E), or double mutant A669D/R725E (A/R, two independent clonal lines, #1 and
#2). A) Structure of VPS33A in complex with VPS16 residues 642–736 (44). VPS33A and VPS16 are shown as white and purple
molecular surfaces, respectively. Inset shows the binding footprint of VPS33A on VPS16 in darker purple, with residues essential for
robust VPS33A binding highlighted in orange. Image was prepared using PyMOL. B and C) Cells were transfected with non-targeting
(NT) siRNA oligonucleotide or VPS16 siRNA oligo3 at 100 nM and subjected to live cell microscopy. Quantiﬁcation of colocalisation
of dextran Alexa Fluor® 488 (green) with Magic Red® (red) shown in (B). Mean± SEM of three independent experiments with ﬁve
ﬁelds each, ≥30 cells total per condition. *p< 0.01, **p< 0.003, ***p< 0.001, NS, not signiﬁcant, using two-tailed unpaired t-test.
Representative confocal microscopy images of cells quantiﬁed in (B) are shown in (C). Scale bar: 2.5 μm. D) Protein lysates were
subjected to immunoprecipitation (IP) with anti-HA afﬁnity matrix and immunoblotting. Overexpressed HA-VPS16 was detected with
an anti-HA antibody and endogenous VPS33A and VPS18 with speciﬁc antibodies. Actin served as loading control.
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affinity matrix, confirmed these results as only VPS16-
GFP and VPS33A-GFP co-immunoprecipitated endoge-
nous VPS18 but no interaction of VIPAR-GFP or
VPS33B-GFP with endogenous VPS18 was detected.
These results were supported by liquid chromatography
tandem mass-spectrometry analysis after immunoprecip-
itation of endogenous VPS18 from HeLaM cells. In this
experiment, peptides of VPS11, VPS16, VPS18, VPS33A
and VPS41 were detected but no peptides of VIPAR or
VPS33B could be found (data not shown). Immunopre-
cipitation experiments from lysates of HeLaM cells stably
expressing both VPS33B-HA and VIPAR-GFP with either
HA or GFP affinity matrices revealed interaction of both
proteins (Figure 6B). Taken together our results show that
human VIPAR and VPS33B are neither present in HOPS
nor CORVET, but form an independent complex.
8 Trafﬁc 2015
HOPS and Lysosome Fusion
Discussion
In this study, we investigated the requirement for HOPS
proteins in the final stages of delivering endocytosed
cargo from endosomes to lysosomes and the fusion of
autophagosomes with lysosomes in mammalian cells. Our
data confirmand extend previous studies showing a role for
mammalianHOPS proteins in these processes by establish-
ing that all the six HOPS proteins (VPS11, VPS16, VPS18,
VPS33A, VPS39 and VPS41) are essential for fusion of
endosomes with lysosomes. Whilst the requirement for all
the HOPS proteins for fusion with vacuoles or lysosomes
is well established in yeast and Drosophila melanogaster
[reviewed in (29,36,50,51)], this has had hitherto not been
shown in mammalian cells in a single study. Prior func-
tional studies on the late endocytic pathway inmammalian
cells either investigated subsets of, or individual, HOPS
proteins using over-expression or depletion approaches
(17,52,53). In the case of the mammalian autophagic path-
way, whilst previous studies have implicated the require-
ment for HOPS proteins in autophagosome–lysosomes
fusion, there has been contradictory evidence concerning
the requirement for VPS16 (27,28,46). Our data implicate
the entire HOPS complex as being essential for the final
stages of delivery to mammalian lysosomes.
We exploited our atomic-resolution structure of the
human VPS33A/VPS16 complex (44) to test the effects
upon HOPS function of tandem mutations in VPS16
(A669D/R725E) that prevent binding to VPS33A
or in VPS33A (K429D/I441K, Y438D/I441K and
K429D/Y438D) that prevent binding to VPS16. Using
depletion/rescue experiments, we observed that the
VPS33A or VPS16 double mutants were unable to support
fusion of lysosomes with endosomes and we also found
that the VPS16 double mutant did not support fusion of
lysosomes with autophagosomes. Taken together, these
experiments showed that recruitment of the SM protein
VPS33A to the remainder of the HOPS complex is essen-
tial for both these fusion events. Unusually amongst SM
proteins, VPS33A lacks a binding site for syntaxin SNARE
protein N-terminal peptides (44,54). The requirement for
VPS33A binding by VPS16 for correct HOPS function is
consistent with the hypothesis proposed for yeast HOPS
that the complex plays the role of the syntaxin N peptide
in other SNARE/SM complexes and recruits VPS33A to
appropriate sites of SNARE-mediated membrane fusion
within the cell (55). This recruitment of VPS33A, and thus
SM protein activity, would allow mammalian HOPS to
contribute to catalysis of trans-SNARE complex assembly,
protection of SNARE complexes from disassembly and to
play a role in lowering the energy barrier for membrane
fusion as suggested for yeast HOPS (10–12,55,56). In
our experiments using cells transfected with pLXIN con-
structs to stably overexpress VPS33A or VPS16 we did not
observe any obvious clustering of endocytic organelles by
Figure 3: VPS33A mutated at its binding interface with VPS16 cannot support endosome-lysosome fusion. Analysis
of HeLaM cells or HeLaM cells stably expressing C-terminally haemagglutinin (HA)-tagged siRNA oligonucleotide 2 (oligo2)-resistant
VPS33A wild type (WT) or the double mutants K429D/I441K (K/I), Y438D/I441K (Y/I) or K429D/Y438D (K/Y). A) Structure of VPS33A
in complex with VPS16 residues 642–736 (44), coloured as in Figure 2A. Inset shows the binding footprint of VPS16 on VPS33A
in darker grey, with residues essential for robust VPS16 binding highlighted in orange. Image was prepared using PyMOL. B and C)
Cells were transfected with non-targeting (NT) siRNA oligonucleotide or VPS33A siRNA oligo2 at 100 nM and subjected to live cell
microscopy. Quantiﬁcation of colocalisation of dextran Alexa Fluor® 488 (green) with Magic Red® (red) shown in (C). Mean± SEM
of three independent experiments with ﬁve ﬁelds each, ≥30 cells total per condition. *p< 0.02, **p< 0.002, ***p< 0.001, NS, not
signiﬁcant, using two-tailed unpaired t-test. Representative confocal microscopy images of cells quantiﬁed in (B) are shown in (C).
Scale bar 2.5 μm. D) Protein lysates were subjected to immunoprecipitation (IP) with an anti-VPS18 antibody and immunoblotting.
Overexpressed HA-VPS33A was detected with an anti-HA antibody and endogenous VPS18 with a speciﬁc antibody. Actin served
as loading control. E) Immunoblot of cell lysates from HeLaM cells, or from HeLaM cells stably overexpressing VPS33A-HA(WT),
VPS33A-HA(K/I), VPS33A-HA(Y/I) or VPS33A-HA(K/Y), transfected twice with non-targeting (NT) siRNA oligonucleotide as a control or
a speciﬁc siRNA pool or single oligo2 to deplete endogenous VPS33A. VPS33A was detected with a speciﬁc VPS33A antibody. Actin
served as a loading control. Expression levels, calculated as an increase compared to endogenous VPS33A in HeLaM cells, were: WT:
ninefold, K/I: fourfold, Y/I: 14-fold, K/Y: ninefold as measured by densitometric analysis of X-ray ﬁlms using IMAGEJ software.
Trafﬁc 2015 9
Wartosch et al.
Figure 4: siRNA depletion of
the HOPS proteins VPS33A
or VPS16 inhibits the fusion
of autophagosomes with
lysosomes. Endogenous VPS16,
VPS33A, VIPAR or VPS33B were
depleted by transfection with
speciﬁc siRNA oligonucleotides
at 100 nM. Transfection with
non-targeting (NT) siRNA oligonu-
cleotide served as control. A)
Confocal images of HeLaM cells
stably expressing the autophagy
marker mRFP-GFP-LC3. Cells were
treated with dimethyl sulphox-
ide (DMSO) (control) or 400 nM
baﬁlomycinA1 (BafA1) to block
autophagosome–lysosome fusion.
Scale bar: 10 μm. B) Representative
confocal images of ﬁxed HeLa cells
that were immunostained for
endogenous LC3 (white). DNA
(blue) was labelled with Hoechst
33258. Scale bar: 10 μm. C) For
each condition, 10 ﬁelds (≥5 cells
per ﬁeld) were imaged for each of
three independent experiments and
the endogenous LC3 ﬂuorescence
signal per area measured using
IMAGEJ. Mean± SEM. *p< 0.04,
**p< 0.01, NS, not signiﬁcant cal-
culated using two-tailed unpaired
t-test.
immunofluorescence microscopy, as previously reported
when other HOPS proteins were transiently overexpressed
(52,53). This is probably due to the presence of a weaker
promoter in pLXIN and consequent lower levels of protein
expression than in the previous studies, in which plasmids
with strong promoters were used. In our depletion/rescue
experiments, the amount of endosome–lysosome fusion
was even greater than in control cells when we rescued
with wild-type HA-VPS16 (Figure 2B). We cannot exclude
the possibility that VPS16 is limiting for the assembly
of functional HOPS complexes and that the increase in
fusion is caused by modest overexpression of wild-type
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Figure 5: Association of VPS33A with the HOPS com-
plex is required for autophagosome-lysosome fusion.
HeLaM cells or HeLaM cells stably expressing HA-tagged siRNA
oligo3-resistant VPS16 wild type (WT), single mutant (A669D,
A725E) or double mutant A669D/R725E (A/R, independent
clonal cell lines #1 and #2) were transfected with non-targeting
(NT), VPS16 pool or VPS16 oligo3 siRNA oligonucleotides at
100 nM. A) Representative confocal images of ﬁxed cells that
were immunostained for endogenous LC3 (white). DNA (blue)
was labelled with Hoechst 33258. Scale bar: 10 μm. B and C)
Cells were subjected to automated measurement of LC3 sig-
nal intensity using a Cellomix® ArrayScan™ VTi microscope. B)
LC3 spot total intensity per object. C) LC3 spot total area per
object. For (B) and (C) fold changes were calculated between
NT and siRNA oligo3 transfected cells (depletion of endogenous
VPS16) of the same genotype. Dotted line indicates levels of
NT-transfected controls. Means± SD of at least 4500 cells per
condition from three independent experiments performed in trip-
licate are shown. *p< 0.02, **p< 0.01, ***p< 0.008, NS, not
signiﬁcant using two-tailed unpaired t-test.
HA-VPS16.We were unable to test this hypothesis because
no suitable, specific VPS16 antibodies were available.
Our depletion experiments provide compelling evidence
that neither VPS33B nor the VPS16 homolog VIPAR
are required for fusion of lysosomes with either endo-
somes or autophagosomes. Moreover, we were unable to
co-immunoprecipitate these proteins with endogenous
VPS18 when tagged versions were stably over-expressed
in HeLaM cells, in contrast to the co-immunoprecipitation
of tagged VPS16 and VPS33A with endogenous VPS18.
Previously, a very low level of co-immunoprecipitation of
co-expressed, tagged VIPAR and VPS33A was observed
in HeLa cells (41). In HEK cells, co-immunoprecipitation
of co-expressed tagged VIPAR and other individual HOPS
proteins was observed and co-sedimentation, in the pres-
ence of a cross-linker, of VPS16 and VPS18 with endoge-
nous or tagged VIPAR was also detected (41). Although
those results appear to be at odds with our present find-
ings, we stress that our experiments cannot rule out a very
low level and/or low affinity interaction of VIPAR and/or
VPS33B with HOPS proteins. However, the experiments
described above together with those reported previously by
ourselves and others (44,57,58), as well as the observation
that VIPAR and VPS33B cluster together but separately
from the HOPS proteins using the proteomic technique of
fractionation profiling (59), argue strongly that in mam-
malian cells VIPAR and VPS33B bind to each other in a
stable complex separate from that formed by the HOPS
proteins. Given the lack of robust interactions with VPS18
we also consider it unlikely that VPS33B is the SM protein
for mammalian CORVET as has been proposed recently
for C. elegans (38). Our hypothesis that mammalian
VIPAR and VPS33B are not part of HOPS or CORVET
is supported by previous evidence that these two proteins
have different functions to their HOPS paralogs in the bio-
genesis of LROs (20,21,41,57,60–63), and that mutations
in the genes encoding VPS33B or VIPAR cause a multi-
system disorder named arthrogryposis, renal dysfunction
and cholestasis syndrome (58,64). Even in cells without
specialized LROs, the localization of VIPAR/VPS33B
may define a specialized endocytic compartment (40,41),
possibly on a recycling pathway to the cell surface, and
thus depletion of these proteins could have pleiomorphic
effects on endocytic traffic and endosome morphology
despite not being required for the final stages of delivery to
lysosomes.
In summary, our data strongly support a model in which
the whole mammalian HOPS complex is required for
endocytic delivery to lysosomes. The binding of the SM
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Figure 6: VIPAR and VPS33B are not part of the
HOPS complex. Immunoprecipitation followed by SDS PAGE
and immunoblotting. A) Lysates of HeLaM cells transiently
expressing GFP or stably expressing VPS16-GFP, VPS33A-GFP,
VIPAR-GFP or VPS33B-GFP were subjected to immunoprecipita-
tion with anti-VPS18 antibody (middle) or GFP-TRAP® agarose
beads (right). Dotted line indicates separate images arising
from different exposure times of membrane. *Heavy chain of
anti-VPS18 antibody used for immunoprecipitation detected
by cross reactivity with HRP conjugated, goat-anti-rabbit
IgG secondary antibody. B) Lysates of HeLaM cells stably
expressing VPS33B-HA that were transiently transfected with
empty GFP vector or stably coexpressing both VPS33B-HA
and VIPAR-GFP were subjected to immunoprecipitation with
anti-HA afﬁnity matrix (middle) or GFP-TRAP agarose beads
(right).
protein VPS33A to the remainder of the HOPS complex
is essential for the fusion of lysosomes with endosomes
or autophagosomes. Our data are consistent with a model
derived mostly from studies in yeast in which HOPS is
required for tethering events and interactions with SNARE
proteins prior to membrane fusion late in the endocytic
and autophagic pathways. We found no evidence that the
VPS16 and VPS33A paralogs VIPAR and VPS33B were
part of the stable HOPS complex in mammalian cells nor
that they had any role late in the endocytic or autophagic
pathways.
Materials and Methods
Mammalian cell culture, microscopy and FACS analysis
HeLaM cells were cultured in RPMI supplemented with 10% (v/v) foetal
bovine serum (FBS), 2mMglutamine, 100U/mLpenicillin and 100 μg/mL
streptomycin. HeLaM cells stably expressing HA-VPS16(WT),
HA-VPS(A669D), HA-VPS16(R725E) (44), HA-VPS16(A669D/R725E),
VPS33A-HA(WT), VPS33A-HA(K429D/I441K), VPS33A-HA(Y438D/
I441K), or VPS33A-HA(K429D/Y438D), VPS16-GFP, VPS33A-GFP,
VIPAR-GFP, VPS33B-GFP, VPS33B-HA, or both VPS33B-HA and
VIPAR-GFP, were generated using the pLXIN retroviral system (Clon-
tech) as previously described (65). HeLaM cells stably expressing
mRFP-GFP-LC3 were as described in (47).
To assess autophagy by immunocytochemistry, cells were plated on glass
coverslips, fixed in 3.4% formaldehyde and permeabilized in 0.1% Triton
X-100 in phosphate buffered saline (PBS), pH7.4. Fixed cells were blocked
with 3% bovine serum albumin (BSA) in PBS before incubation with
primary LC3 antibody (MBL) followed by AlexaFluor488-conjugated
secondary antibody (Invitrogen) and Hoechst 33258 staining. Images
were acquired on a Zeiss LSM710 confocal microscope with Zeiss ZEN
software. Total LC3 fluorescence intensity from at least 10 fields (≥5
cells per field) for each of three independent experiments was measured
using IMAGEJ software package and normalized to cell area. Automated
quantification of LC3 spot total intensity and total area per object
was performed on cells cultured in black PerkinElmer 96-well view
plates using a Cellomix® ArrayScan™ VTi High Content Screening
Microscope (Cellomics) and the Spot Detector V4 algorithm. In short,
immunohistochemistry was performed and nuclei were labelled with
Hoechst 33258 to identify individual cells. Flow-Check™ 675 fluoro-
spheres [APC (675/633) Set-up Kit, Beckman Coulter] were used to
adjust the plane of focus and the total fluorescence intensity or total
area of LC3 spots per cell was measured from at least 3 wells, with
≥500 cells per well for each condition. Fold changes were calculated
by dividing results from siRNA oligo3 transfected cells by the results
of non-targeting siRNA treated controls of the same genotype. Results
presented are from three independent experiments and significance was
calculated by two-tailed t-test with pairing of samples from individual
experiments.
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To measure the delivery of endocytosed dextran to lysosomes by quan-
titative live cell confocal microscopy, cells were first loaded for 2 h with
1mg/mL dextran Alexa Fluor 488 10 000MW, anionic, fixable (Life Tech-
nologies) in RPMI followed by a chase for 1 h in dextran-free RPMI. Cells
were then rinsed with PBS, incubated in Magic Red®MR-(RR)2 Cathep-
sin B substrate (1:2600 dilution) (ImmunoChemistry Technologies)
in Live Cell Imaging Solution (Molecular Probes® Life Technologies).
Magic Red® is a membrane permeable substrate for the lysosomal
acid hydrolase Cathepsin B. The bi-substituted cresyl violet groups in
Magic Red® are non-fluorescent until they are cleaved at one or both
arginine amide linkage sites by Cathepsin B in lysosomes (66). After
cleavage mono- and non-substituted cresyl violet emits red fluorescence
when exited at 550–590 nm. After adjustment to 37∘C in the heating
chamber of a Zeiss inverted confocal microscope, single confocal images
corresponding to 1 Airy unit were taken (three independent experiments
with≥5 fields each per condition, average of 1–2 cells per field, randomly
selected). The degree of colocalisation of two channels reflecting the
fraction of dextran Alexa Fluor 488 colocalising with Magic Red® was
measured by Manders M1/M2 colocalisation coefficients (67) using ZEN
software (Carl Zeiss). For analysis of total dextran Alexa Fluor 488 or
Magic Red® fluorescence, cells were treated as described above and
subjected to FACS analysis by a five-laser LSR Fortessa (BD Biosciences)
and the results of 30,000 cells per condition in each of three independent
experiments were analysed with FLOWJO software.
siRNA-mediated knock-down
siRNA oligonucleotides targeting human gene products were designed
and synthesized by Dharmacon/Thermo Scientific. HeLaM cells were
transfected (two transfections separated by 48 h) using Oligofectamine
(Life Technologies) according to the manufacturer’s protocol. On-Target
Plus oligonucleotide catalogue numbers were as follows: non-targeting
(NT) control (D-001810-01), VPS11 SMARTpool (L-007022-00),
VPS16 SMARTpool (L-013003-01), VPS18 SMARTpool (L-013178-00),
VPS33A SMARTpool (L-013330-01), VPS33A (J-013330-10-0002;
oligo2 target sequence is 5′-GAAGAAACGUCAACCGGGA), VPS39
SMARTpool (L-014052-01), VPS41 SMARTpool (L-006972-00), VPS33B
SMARTpool (L-007261-01), VIPAR SMARTpool (L-016131-01).
siGENOME oligonucleotide catalogue numbers were: VPS16 SMART-
pool (M-013003-00), VPS16 (D-013003-03; oligo3 target sequence
is 5′-AGAAAUCACCCAUUGGCUA). For knock-down of VPS16
with SMARTpool oligonucleotides, ON-Target Plus and siGENOME
SMARTpool oligonucleotides were mixed at a 1:1 ratio.
Quantitative real-time PCR (qPCR)
Total RNAs were isolated from about 1million cells using the RNeasy
Mini Kit (Qiagen). RNA template (1 μg) was used for cDNA synthe-
sis using the QuantiTect Reverse Transcription Kit (Qiagen), which
includes depletion of genomic DNA. cDNAs were used for Quan-
titative PCR (qPCR) using SYBR Green Jumpstart Taq ReadyMix
(Sigma-Aldrich) or SYBR Select Master Mix (Applied Biosystems) on
a QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems).
Primers (Table S1) were designed using the NCBI primer-blast tool
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). qPCR results were
analysed using the comparative ΔΔCt method (68). Non-targeting
siRNA transfected cells were used as a reference sample. Samples of three
biologically independent experiments were analysed and the standard
deviations of ΔΔCt values calculated.
Immunoprecipitation and immunoblot analysis
HeLaM cells used for immunoprecipitation experiments were stably
expressing VPS16-GFP, VPS33A-GFP, VIPAR-GFP, VPS33B-GFP,
HA-VPS16, VPS33B-HA, or both VPS33B-HA and VIPAR-GFP, or were
transiently transfected with pEGFP-N1 vector (Clontech) using PEI
transfection reagent as previously described (69). Cells were harvested
into lysis buffer containing 50mM Tris–HCl (pH 7.4), 150mM NaCl,
0.4 or 1% IGEPAL CA-630 (Sigma-Aldrich), and Complete protease
inhibitors (Roche) and subjected to immunoprecipitation with polyclonal
anti-VPS18 antibody, GFP-TRAP® coupled agarose beads (Chromotek),
or anti-HA affinity matrix (Roche) as previously described (44). In
short, lysates were adjusted to 6 μg/μL total protein and precleared by
incubation for 30min with protein-A sepharose. For immunoprecipi-
tation precleared lysates were incubated with equilibrated GFP-TRAP
agarose beads (Chromotek) or anti-HA affinity matrix (Roche) for 3 h at
4∘C. For immunoprecipitation with an anti-VPS18 antibody, precleared
lysates were incubated with anti-VPS18 antibody for 2 h at 4∘C before
equilibrated protein-A sepharose was added for 1 h to enable capture
of antibody-protein complexes. Protein samples were boiled for 10min
before being subjected to SDS-PAGE and immunoblot analysis on
Immobilon-PVDF membrane (Millipore) using the Mini-Protean and
Mini-Trans-Blot systems (BioRad) following the manufacturer’s protocol.
To quantitate VPS33A levels X-ray films were scanned and subjected to
densitometric analysis using IMAGEJ software. Each VPS33A signal was
normalized to the Actin signal of the respective sample.
Antibodies
The antibodies used were: Polyclonal rabbit anti-VPS18 and poly-
clonal rabbit anti-VPS33A [both as described (44)], polyclonal rabbit
anti-Actin (A2066; Sigma-Aldrich), monoclonal mouse anti-HA (HA.11,
MMS-101R; Covance), polyclonal rabbit anti-GFP (70), monoclonal
mouse anti-LC3 (4E12, M152-3, MBL, used for immunofluorescence
staining), polyclonal HRP conjugated goat-anti-rabbit IgG (A9169;
Sigma-Aldrich) and polyclonal HRP conjugated rabbit-anti-mouse IgG
(A9044; Sigma-Aldrich).
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Supporting Information
Additional Supporting Information may be found in the online version of
this article:
Table S1. Primers for quantitative real-time PCR (qPCR).
Figure S1. Components of the human HOPS complex but not VIPAR
or VPS33B are required for efficient late endosome-lysosome fusion.
HeLaM cells were transfected with siRNA oligonucleotides at 100 nM and
loaded with 10,000MW dextran Alexa Fluor® 488 (green) for 2 h. After
a chase in medium free of fluorescent dextran for 1 h, lysosomes were
stained with Magic Red® (red) and cells subjected to live-cell confocal
imaging. Shown are total images of the representative blow-ups (right)
that were shown in Figure 1C. Scale bar: 10 μm.
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